The Quest for Longevity: Sam Altman Backs $1 Billion Push to Extend Human Lifespan
"Sam Altman's quest for immortality: Retro Biosciences aims to extend human lifespan by 10 years."
Matilda
The Quest for Longevity: Sam Altman Backs $1 Billion Push to Extend Human Lifespan
The pursuit of extending human lifespan has long captivated humanity. Now, with advancements in biotechnology and artificial intelligence, this pursuit is entering a new era. Leading this charge is Retro Biosciences, a San Francisco-based biotech startup backed by OpenAI CEO Sam Altman. Retro Biosciences: A Bold Mission Retro Biosciences is on a mission to extend human lifespan by 10 years beyond what they define as a "healthy" lifespan. They aim to achieve this by developing novel therapies that target age-related diseases such as Alzheimer's, Parkinson's, and cardiovascular diseases. Altman Doubles Down on Longevity Sam Altman, renowned for his role in the AI revolution through OpenAI, has shown unwavering support for Retro Biosciences. He previously invested in the company's seed round, providing a significant $180 million. Now, he's doubling down by participating in their ambitious $1 billion Series A funding round. AI-Powered Breakthroughs Retro Biosciences is…